{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:00:42Z","timestamp":1768406442083,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15418-9","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T03:33:54Z","timestamp":1765164834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotactic re-irradiation for lymph node recurrence of breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Zied","family":"Fessi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salom\u00e9","family":"Bonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoutar","family":"Lodyga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00ebl","family":"Barthoulot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Delerue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Dworczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"15418_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00404-021-06352-9","volume":"306","author":"I Ge","year":"2022","unstructured":"Ge I, Erbes T, Juhasz-B\u00f6ss I. Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature. Arch Gynecol Obstet. 2022;306:943\u201357.","journal-title":"Arch Gynecol Obstet"},{"key":"15418_CR2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","volume":"402","author":"C Taylor","year":"2023","unstructured":"Taylor C, Dodwell D, McGale P, Hills RK, Berry R, Bradley R, et al. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Lancet. 2023;402:1991\u20132003.","journal-title":"Lancet"},{"key":"15418_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307\u201316.","journal-title":"N Engl J Med"},{"key":"15418_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12885-019-5710-5","volume":"19","author":"B Holleczek","year":"2019","unstructured":"Holleczek B, Stegmaier C, Radosa JC, Solomayer EF, Brenner H. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany. BMC Cancer. 2019;19:520.","journal-title":"BMC Cancer"},{"key":"15418_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamasurg.2023.2150","volume":"158","author":"JH Cheun","year":"2023","unstructured":"Cheun JH, Kim HK, Moon HG, Han W, Lee HB. Locoregional recurrence patterns in patients with different molecular subtypes of breast cancer. JAMA Surg. 2023;158:841\u201352.","journal-title":"JAMA Surg"},{"key":"15418_CR6","first-page":"271","volume":"89","author":"S Cranenbroek","year":"2005","unstructured":"Cranenbroek S, van der Sangen MJC, P. Kuijt G, Voogd AC. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat. 2005;89:271\u20135.","journal-title":"Breast Cancer Res Treat"},{"key":"15418_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/jnci\/92.14.1143","volume":"92","author":"JA van Dongen","year":"2000","unstructured":"van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143\u201350.","journal-title":"J Natl Cancer Inst"},{"key":"15418_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1470-2045(13)70589-8","volume":"15","author":"S Aebi","year":"2014","unstructured":"Aebi S, Gelber S, Anderson SJ, L\u00e1ng I, Robidoux A, Mart\u00edn M, et al. Chemotherapy for isolated locoregional recurrence of breast cancer: the CALOR randomised trial. Lancet Oncol. 2014;15:156\u201363.","journal-title":"Lancet Oncol"},{"key":"15418_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","volume":"36","author":"IL Wapnir","year":"2018","unstructured":"Wapnir IL, Price KN, Anderson SJ, Robidoux A, Mart\u00edn M, Nortier JWR, et al. Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol. 2018;36:1073\u20139.","journal-title":"J Clin Oncol"},{"key":"15418_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-023-00508-3","volume":"9","author":"V Debien","year":"2023","unstructured":"Debien V, De Caluw\u00e9 A, Wang X, Piccart-Gebhart M, Tuohy VK, Romano E, et al. Immunotherapy in breast cancer: an overview of current strategies and perspectives. NPJ Breast Cancer. 2023;9:1\u201310.","journal-title":"NPJ Breast Cancer"},{"key":"15418_CR11","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","volume":"23","author":"N Andratschke","year":"2022","unstructured":"Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, et al. European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23:e469\u201378.","journal-title":"Lancet Oncol"},{"key":"15418_CR12","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.adro.2020.100640","volume":"6","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, et al. Reirradiation for locoregional recurrent breast cancer. Adv Radiat Oncol. 2020;6:100640.","journal-title":"Adv Radiat Oncol"},{"key":"15418_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ijrobp.2015.12.361","volume":"94","author":"NR Datta","year":"2016","unstructured":"Datta NR, Puric E, Klingbiel D, Gomez S, Bodis S. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94:1073\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15418_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","volume":"117","author":"JM Hannoun-Levi","year":"2023","unstructured":"Hannoun-Levi JM, Gal J, Polgar C, Strnad V, Loessl K, Polat B, et al. Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO oncological outcome and prognostic factor analysis. Int J Radiat Oncol Biol Phys. 2023;117:1200\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15418_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.radonc.2013.03.026","volume":"108","author":"JM Hannoun-Levi","year":"2013","unstructured":"Hannoun-Levi JM, Resch A, Gal J, Kauer-Dorner D, Strnad V, Niehoff P, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol. 2013;108:226\u201331.","journal-title":"Radiother Oncol"},{"key":"15418_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.adro.2020.07.017","volume":"5","author":"T Smith","year":"2020","unstructured":"Smith T, O\u2019Cathail SM, Silverman S, Robinson M, Tsang Y, Harrison M, et al. Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer: outcomes and toxicity. Adv Radiat Oncol. 2020;5:1311\u20139.","journal-title":"Adv Radiat Oncol"},{"key":"15418_CR17","first-page":"61","volume":"4","author":"E Maranzano","year":"2016","unstructured":"Maranzano E, Draghini L, Anselmo P, Casale M, Arcidiacono F, Chirico L, et al. Lung reirradiation with stereotactic body radiotherapy. J Radiosurg SBRT. 2016;4:61\u20138.","journal-title":"J Radiosurg SBRT"},{"key":"15418_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.736690","volume":"11","author":"P Lemoine","year":"2021","unstructured":"Lemoine P, Bruand M, Kammerer E, Bogart E, Comte P, Royer P, et al. Stereotactic body radiation therapy for oligometastatic breast cancer: a retrospective multicenter study. Front Oncol. 2021;11:736690.","journal-title":"Front Oncol"},{"key":"15418_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","volume":"6","author":"D Pasquier","year":"2023","unstructured":"Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM, et al. The safety and efficacy of salvage stereotactic radiation therapy in patients with intraprostatic tumor recurrence after previous external radiation therapy: phase 1 results from the GETUG-AFU 31 study. Eur Urol Oncol. 2023;6:399\u2013405.","journal-title":"Eur Urol Oncol"},{"key":"15418_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2023.08.064","volume":"118","author":"E Zabrocka","year":"2024","unstructured":"Zabrocka E, Polce S, Roberson JD, Wu J, Cohen J, Baer L, et al. Utility of stereotactic body radiation therapy in establishing local control for patients with invasive breast cancer not undergoing definitive surgery. Int J Radiat Oncol Biol Phys. 2024;118:436\u201342.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15418_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","volume":"195","author":"L Wilke","year":"2019","unstructured":"Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, et al. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol. 2019;195:193\u20138.","journal-title":"Strahlenther Onkol"},{"key":"15418_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.53011\/JMRO.2021.02.07","volume":"1","author":"T Popescu","year":"2021","unstructured":"Popescu T, Chiorean A, Schultes N, Iacob C, Eniu D. SBRT as salvage re-irradiation for isolated in field regional relapse after bilateral breast cancer \u2013 a case report. J Med Imaging Radiat Oncol. 2021;1:63\u20139.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"15418_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.37549\/ARO1140","volume":"4","author":"S Rice","year":"2017","unstructured":"Rice S, Rosenblatt P, Feigenberg S. Management of internal mammary nodal recurrence after palliative mastectomy and postoperative radiation therapy in triple negative breast cancer. Appl Radiat Oncol. 2017;4:34\u20136.","journal-title":"Appl Radiat Oncol"},{"key":"15418_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184515","volume":"15","author":"J Baude","year":"2023","unstructured":"Baude J, Dendale R, Cao K, Fourquet A, Kirova Y. Tolerance and oncological outcomes of in-field reirradiation for locally recurrent breast cancer: a long-term single-center experience. Cancers (Basel). 2023;15:4515.","journal-title":"Cancers (Basel)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15418-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:04:36Z","timestamp":1768385076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15418"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15418-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data were collected from hospital records without any patient interaction. The Commission for Clinical Studies of the Oscar Lambret Center approved the study (CEC-2023-023) and confirmed that independent ethics committee approval was not required. The study complies with the Reference Methodology MR004 of the French National Commission on Informatics and Freedoms (CNIL \u201cCommission Nationale Informatique et Libert\u00e9\u201d). Due to the retrospective nature of the study, Centre O. Lambret Review Board waived the need of obtaining specific informed consent. All patients were informed, and none objected to the use of their medical data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}